Download PDF
1 / Pages

Other users also viewed these articles

Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease¿EXVEDOCOL Viviana Parra; Sandra Cifuentes; Sandra Avendaño; Enrique Ponce de León; Cristian Florez; Gustavo Reyes; Fabian Puentes; Manuel Ballesteros; Edilberto Nuñez; Federico Gómez; Juan Ricardo Márquez;
Gastroenterol Hepatol. 2024;47:858-66
Ultra-short celiac disease exhibits differential genetic and immunophenotypic features compared to conventional celiac disease Pilar Mata-Romero; Daniel Martín-Holgado; Hal C. Ferreira-Nossa; Pedro L. González-Cordero; Ana Izquierdo-Martín; Patricia Barros-García; Nuria Fernandez-Gonzalez; Luis Fernández-Pereira; Carmen Cámara-Hijón; Javier Molina-Infante;
Gastroenterol Hepatol. 2022;45:652-9
Perception and clinical decisions from inflammatory bowel diseases¿ specialists towards positioning of new therapies in Crohn's disease and ulcerative colitis: A national web-based survey from the Brazilian IBD study group (GEDIIB) Roberta Krause Romero; Daniela Oliveira Magro; Natalia Sousa Freitas Queiroz; Aderson Omar Mourão Cintra Damião; Fabio Vieira Teixeira; Rodrigo Bremer Nones; Ligia Yukie Sassaki; Rogerio Saad-Hossne; Paulo Gustavo Kotze;
Gastroenterol Hepatol. 2022;45:499-506